Yoshiyuki Wada - Concepedia

Author

Yoshiyuki Wada

Also Known As

Tetsuya Toge, Wada Yoshiyuki, Wada, Y., Y Wada, Y. B. Wada, Y. Wada, Y., Wada, Yasuhiko Wada, Yoshihiro WADA, Yoshiyuki WADA

191

Publications

Citations

H-Index

101

Concepts

All Affiliations

National Kyushu Medical Center Kindai University National Cancer Center Hospital East Hiroshima University Kurume University

About

Yoshiyuki Wada is an author at National Kyushu Medical Center specializing in medicine, hepatology, and hepatocellular carcinoma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	32	1.2K
2	Health Sciences	10	10	343
3	Education	2	2	109
4	Engineering	1	1	49
5	Natural Sciences	1	1	172

Yoshiyuki Wada

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, Gut	2019	686
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan, Cancers	2019	291
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma B. Sangro, Stephen L. Chan, Robin Kate Kelley, Annals of Oncology	2024	254
Different Clinicopathologic Findings in Two Histologic Types of Carcinoma of Papilla of Vater Wataru Kimura, Noriaki Futakawa, Seiichi YAMAGATA, Japanese Journal of Cancer Research	1994	252
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset Tatsuya Yamashita, Masatoshi Kudo, Kenji Ikeda, Journal of Gastroenterology	2019	217
Genetic Epidemiology of the Carnitine Transporter OCTN2 Gene in a Japanese Population and Phenotypic Characterization in Japanese Pedigrees with Primary Systemic Carnitine Deficiency Akio Koizumi, Jun-nichi Nozaki, T. Ohura, Human Molecular Genetics	1999	176
Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals Ryuichi Fujisawa, Yoshiyuki Wada, Yoshinobu Nodasaka, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology BiochemistryHydroxyapatiteNatural SciencesAcid-rich SequencesMolecular Biology	1996	172
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri, The Lancet HepatologyTransarterial ChemoembolisationMedicinePharmacologyPathology	2025	151
Quantitative trait loci (QTL) analysis in a Meishan×Göttingen cross population Yoshiyuki Wada, Tomiji AKITA, Takuya Awata, Animal Genetics	2000	129
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, Liver Cancer	2022	118

Page 1